Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
allogeneic umbilical cord-derived mesenchymal stem cells (EN001) / ENCell
NCT06328725: Evaluate the Efficacy and Safety of EN001 in Patients With Duchenne Muscular Dystrophy	Not yet recruiting	1/2	88	RoW	EN001, EN001(allogenic early-passage mesenchymal stem cells derived from Wharton's jelly (WJ-MSCs) )	ENCell	Duchenne Muscular Dystrophy	11/25	11/25
NCT05333406: Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease (CMT) Type 1A	Completed	1	9	RoW	EN001, EN001 (allogeneic umbilical cord-derived mesenchymal stem cells)	ENCell	Charcot-Marie-Tooth Disease, Type IA	12/22	12/22
NCT05338099: Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD)	Completed	1	7	RoW	EN001, EN001 (Allogeneic early-passage Wharton's jelly-derived mesenchymal stem cells)	ENCell	Duchenne Muscular Dystrophy	12/22	12/22
NCT06328712: Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A	Recruiting	1	12	RoW	EN001, EN001(allogenic early-passage mesenchymal stem cells derived from Wharton's jelly (WJ-MSCs) )	ENCell	Charcot-Marie-Tooth Disease Type 1A	10/24	10/24
NCT06218134: Evaluate the Safety and Potential Efficacy of Human Wharton's Jelly-derived Mesenchymal Stem Cells With Charcot-Marie-Tooth Disease Type 1E	Not yet recruiting	N/A	3	NA	human Wharton's jelly-derived mesenchymal stem cells	Samsung Medical Center	Charcot-Marie-Tooth Disease, Type 1	12/24	12/24